Queen Mary University of London: Drug that Targets Immune Cells Shows Potential as Treatment for Diabetic Heart Disease
February 28, 2026
February 28, 2026
LONDON, England, Feb. 28 (TNSjou) -- Queen Mary University of London issued the following news:
* * *
Drug that targets immune cells shows potential as new treatment for diabetic heart disease
Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage -- not by controlling blood sugar as originally intended, but by retraining the immune system to protect the heart . . .
* * *
Drug that targets immune cells shows potential as new treatment for diabetic heart disease
Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage -- not by controlling blood sugar as originally intended, but by retraining the immune system to protect the heart . . .
